Male Contraception

In this episode of AUANews Inside Tract, Igniting Discovery, Kevin Eisenfrats, CEO of Contraline and 2025 Innovation Nexus Showcase winner, discusses the development of two novel male contraceptives, a daily hormonal gel (NEST) and a long-lasting, reversible implant (ADAM). He shares insights on...

OG in the field here! Dr. Christina Wang Q&A EmpowHER the Patient is a podcast series highlighting the accomplishments and attitudes of change makers advancing women’s health and empowerment across Los Angeles. This first episode of the series features Dr. Christina Wang who is a...

Transdermal gel application pump. The gel is filled into 90 mL metered dose pumps designed to dispense 2.5 mL/actuation. Two of these bottles allow monthly treatment of 5 mL/d. The daily dose delivers 8 mg of Nestorone (NES) and 74 mg of testosterone (T), of which 10% are absorbed; 0.8 mg of NES...

Purpose of review Rates of unintended pregnancy have remained relatively stagnant for many years, despite a broad array of female contraceptive options. Recent restrictions on access to abortion in some countries have increased the urgency for expanding contraceptive options. Increasing data...